The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential

Authors

Keywords

Journal

Volume 384, Issue 4, Pages 471-475

Publisher

Elsevier BV

Online

2009-05-06

DOI

10.1016/j.bbrc.2009.04.136

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now